Background
Helicobacter pylori are Gram-negative bacteria that colonize the gastric mucosa of humans across the world. However,
H. pylori is disappearing from populations in developed countries[
1,
2]. In developing countries, up to 90% of the adult population carries the organism[
3,
4].
H. pylori is acquired early in life[
5,
6] and generally persists unless hosts are treated with antibiotics[
1]. Gastric
H. pylori colonization increases risk of peptic ulcer disease as well as adenocarcinoma of the distal stomach[
7]. In addition to negative effects late in life, there is now evidence that
H. pylori may protect against early-onset asthma[
8‐
10] and gastrointestinal infections[
11‐
13], thus providing benefits early in life. Because Rhesus macaques usually are persistently colonized with
H. pylori and develop chronic gastritis[
13,
14], they represent a model to study host interactions.
Campylobacter jejuni are Gram-negative bacteria that are among the leading causes of acute gastroenteritis worldwide[
15]. Sequelae of
C. jejuni infections may include the Guillain–Barré syndrome and reactive arthritis[
16‐
18].
C. jejuni infections are known to be highly prevalent within monkey colonies, especially when the animals are living under non-natural conditions[
19]. Despite recent advances[
20‐
24], the colonization dynamics of
H. pylori and
C. jejuni in macaques in relation to infection in humans have been little examined. The purpose of this study was to (I) establish reliable serological assays to detect monkey antibodies to
H. pylori- and
C. jejuni-specific antigens and (II) to investigate the sero-prevalence of
H. pylori and
C. jejuni in a social-group of Rhesus macaques. We hypothesized that a group of monkeys with constant contact with each other would be manifested by a high prevalence of responses to these enteric organisms, similar to those shown by humans before the introduction of antibiotics and better hygienic standards. Such assays could provide models to study
H. pylori spread, eradication, and putative positive and negative effects in individuals and in populations.
Discussion
The original habitats of Rhesus macaques range from Central to Southeast Asia[
31]. However, populations of Rhesus macaques have been living in captivity for generations, since they are the most important non-human primates used for medical and biological research[
32‐
36]. For this study, we analyzed gastric biopsies and blood samples from the animal facility at the Uniformed Services University of the Health Sciences, to establish reliable cut-off values for detecting
H. pylori antibodies (Cohort 1). To investigate the sero-prevalence of responses to
H. pylori and
C. jejuni antigens in social Rhesus macaques, we studied blood samples routinely taken from a population of animals living together in one outdoor cage in the Caribbean Primate Research Center since 1984 (Cohort 2). We sought to determine how prevalent
H. pylori and
C. jejuni-specific antibodies are in a group of Rhesus macaques to evaluate whether the colonization rates of monkeys are similar to human populations.
Although
H. pylori and
C. jejuni are phylogenetically close, they differ substantially in the nature of their antigens[
37], even including conserved proteins like their heat-shock protein 60[
38]. Among other factors, flagellae proteins[
39], adhesins and outer membrane proteins differ considerably between
C. jejuni and
H. pylori[
40]. In this study we used water-extracted proteins as antigens. Potential cross-reactions between
H. pylori and
Campylobacter antigens have been addressed in previous studies[
41,
42] and are considered to be of minor significance[
43]. Moreover, the immune response to CagA is specific for
H. pylori and no cross-reactions have been described.
Using the biopsy and blood samples from Cohort 1, we were able to establish ELISAs that were 100% specific and 93% sensitive for
H. pylori IgG detection, and 100% sensitive for CagA IgG. In contrast, the IgA ELISA was much less specific and sensitive and as is the case with humans[
44], not sufficiently accurate for classification of
H. pylori status in Rhesus macaques.
The determined ELISA parameters were used to evaluate Cohort 2 for
H. pylori prevalence. In developed countries,
H. pylori is disappearing[
1,
2] but in developing countries,
H. pylori prevalence remains high[
3,
4]. The prevalence of
H. pylori in monkeys clearly increases with age. In the oldest monkeys, positivity increased to 94%. Even using a more stringent IgG and IgA double positive criterion to classify monkeys as
H. pylori-colonized, the trends remain the same and the same age-dependency was observed for the CagA IgG ELISA. Parallel age trends are commonly observed in studies conducted in human populations[
27,
45]. However, in contrast to humans, younger Rhesus macaques have the same likelihood to have a CagA-positive strain as do the macaques in the oldest group. Comparing double- (44%) and triple- (29%) positive rates, about 67% of the
H. pylori-positive monkeys were colonized with a CagA + strain. This is comparable to the situation among humans in developing countries[
27,
45]. In summary, the socially living Rhesus macaques in captivity resemble the pre-modern situation for
H. pylori colonization. One possible route of acquiring
H. pylori in younger monkeys is by oral-oral contact[
46] with older monkeys. Free-living monkeys and monkeys in captivity have close contact with each other, making it impossible to trace infection routes back to parents, siblings, aunts or playmates, without the ability to genotype the strains. How the Rhesus macaques originally acquired
H. pylori also remains unclear. Genotyping would help to elucidate whether the strains are of human origin, and whether such strains were introduced into the Rhesus macaque population before or after they were captured in 1938 and brought to Cayo Santiago Island (i.e. carrying an Asian strain). Strain isolation from gastric biopsies and multi-locus sequence typing (MLST) analysis could help answer these questions.
To determine the cut-off values for the
C. jejuni ELISA, we used blood samples from humans of known
C. jejuni status[
28]. The tested 94 monkeys did not show any signs of diarrhea at the time of sampling and had no evidence of acute infection. In contrast to
H. pylori, there was no correlation between age and
C. jejuni sero-positivity. In general, the prevalence of
C. jejuni IgG was equally high in all the groups, with a significant drop of prevalence of IgG antibodies in juvenile Rhesus macaques. However, a high prevalence of
C. jejuni IgA was observed in that group. In areas in which
C. jejuni infection is hyper-endemic and infection is recurrent, young children develop high levels of specific serum IgG antibodies. With continued exposure, IgG levels wane and IgA levels rise[
29,
30], and the duration of colonization diminishes reflecting development of gut immunity[
36]. The drop in IgG between infant and juvenile macaques that we observed is consistent with this phenomenon. As in humans,
C. jejuni causes transient infection in Rhesus macaques and specific antibodies are detected in convalescence[
47].
Methods
Animals studies
Two cohorts of Rhesus macaques were studied. Cohort 1 consisted of 30 domestic male Rhesus macaques (Macaca mulatta) [2 to 7 years old and weighing 3–5 kg] from the animal facility at the Uniformed Service University of the Health Sciences in Bethesda, Maryland. Samples were collected between January 1988 to May 1995. Upon arrival to the facility, these monkeys had been quarantined for 90 days in individual stainless steel cages in conventional holding rooms of the animal facility [approved by The American Association for Accreditation of Laboratory Animal Care (AALAC)] and were subsequently kept in similar individual cages. Animals were provided with tap water ad libitum, commercial primate chow, and fruit. All subsequent studies were performed after an overnight fast, between 8 am and noon.
The studied social group of monkeys (Cohort 2) consisted of 94 Rhesus macaques housed in the Caribbean Primate Research Center in Sabana Seca, Puerto Rico. These animals are descendants of monkeys brought to the Research Center in 1984 from the free-ranging colony on Cayo Santiago Island. They are co-housed and are in constant contact with one another. Serum samples were collected between December 2008 and April 2010. The studies were performed in a cross-sectional design for determination of H. pylori and C. jejuni status, according to age. The Rhesus macaques (Cohort 2, N = 94, 60 females, 34 males) were assigned to groups according to age: group 1 (Infant) includes monkeys <1 year [N = 32 (17 females/15 males)]; group 2 (Juvenile) monkeys were 1.0-2.9 years [N = 24(18/6)]; group 3 (Young Adult) monkeys were 3.0-9.9 years [N = 21(12/9)] and group 4 (Adult) consisted of all monkeys ≥10 years of age [N = 17(13/4)]. Of the 32 monkeys in group 1, five (3 female, 2 male) <0.5 years were excluded from serological analysis, due to potential maternal antibodies.
Endoscopic procedures and biopsies
The 30 Rhesus macaques of Cohort 1 underwent gastroduodenal endoscopic examination under general anesthesia, essentially as described[
13]. From each animal, six pinch biopsies of the gastric corpus and six from gastric antral mucosa were obtained. Two biopsies from each region were fixed in neutral 10% buffered formalin and embedded in paraffin. Biopsy sections were stained with haematoxylin and eosin or Genta’s method and viewed under 100x to 1,000x magnification. The presence of inflamamatory cells in the biopsies was scored on coded slides, as described[
47]; as were the presence of stained
H. pylori organisms, as described[
13]. Two other biopsies from antrum and corpus were immediately placed in 0.1 ml sterile 0.9% NaCl on ice and processed for
H. pylori isolation, as described[
47].
H. pylori isolates were identified as pinhead-colonies, urease-, oxidase- and catalase-positive, and were Gram-negative curved or “gull-wing” rods.
Measurement of H. pylori-specific antibodies in Cohort 1
From each Rhesus macaque at the time of each endoscopy, five milliliters of blood was collected in tubes containing 10.5 mg of EDTA and centrifuged; the supernatant plasma was frozen at −70°C. The monkey samples were diluted 1:800 for IgG and 1:100 for IgA. Anti-
H. pylori immunoglobulin G (IgG) and A (IgA) levels in the plasma were determined, using a modification of a method with high sensitivity and specificity for human
H. pylori positivity, as described[
13,
41]. In brief, the
H. pylori antigens, composed of a mixture of protein and lipopolysaccharides from five
H. pylori strains (ATCC 53722, 53721, 53725, 53726, and 53727), were obtained by water extraction and sonication, as described[
41]. The mixture was diluted in 0.05 M carbonate buffer (pH 9.6) to coat each well of a flat-bottom ELISA-plate with 1.0 mg antigen. Plates were coated overnight at 4°C and then blocked for 3 h with 1x PBS containing 0.05% Tween-20, 0.1 mg/ml thimerosal, and 0.1% gelatin. Serum samples were added and plates were incubated for 1 h at 37°C. All washing steps were performed with 1x PBS containing 0.05% Tween-20 and 0.1 mg/ml thimerosal. Goat anti-monkey IgG (gamma chain) or IgA (alpha chain) conjugated to horseradish peroxidase (Rockland Immunochemicals Inc., Gilbertsville, PA) was used as second antibody for detection of responses. A cut-off value was established to distinguish between positive and negative results in the IgG enzyme-linked immunosorbent assay (ELISA) by determining ODR-values (optical density ratio). ODRs were determined for each sample by dividing the OD-value of the sample by the OD-value of two positive controls for
H. pylori and
C. jejuni IgA and IgG and one positive control for
H. pylori CagA, which were included on each ELISA plate as reference specimens. Using 9 Rhesus macaques found to be
H. pylori negative by tissue examination (negative culture or histology), the mean ODR-value plus 3 intervals of standard deviation (SD) from those animals was used to define the threshold for negativity (0.34). For IgA, the mean value of 9 uninfected monkeys plus 2 intervals of SD was used to define the threshold for negativity (0.44). An ELISA to detect anti-CagA IgG in plasma from the monkeys was performed using a purified recombinant CagA antigen, as described[
48]. The assay was modified with the use of a goat anti-monkey IgG (gamma chain) conjugate. The monkey plasma was diluted 1:100. A cut-off value was established to distinguish between positive and negative CagA results based on the 9 monkeys found by tissue exam to be
H. pylori-negative. The mean value plus 2 intervals of SD for the 9 animals was used to define the threshold for positivity (0.20).
Measurement of H. pylori-specific antibodies in Cohort 2
For cohort 2, ELISAs were performed as described above. Each sample was tested twice and in the case of disparate results, a third measurement was performed. If samples had discordant ODR-values in the two runs (values close to the negative and positive controls, respectively), we assumed that at least one value was an artifact, and the assay repeated. An assay also was repeated when the ODR-values were close to the threshold values
. Resulting ODRs were averaged and evaluated using the determined cut-off values from the reference values from Cohort 1. Additionally, Cohort 2 values were statistically analyzed to evaluate whether the same cut-off values could be obtained without using the reference group. To obtain the cut-off for positive samples, the mean of ODRs between 0.4-1.0 was calculated and 2 times the SD was subtracted, providing a cut-off for positivity (a summary of all values is provided in Table
3). To determine the negative cut-off, the mean of ODRs between 0.000-0.299 was calculated and two times the SD was added. Values between 0.300-0.399 were only excluded for the statistical analysis of the cut-off values. After establishing the cut-off values for positivity and negativity, ODRs between 0.300-0.399 were assigned according to these values.
C. jejuni ELISAs
Since antigens from sonicated whole
C. jejuni cells did not yield reliable results for serology (not shown), the McCoy antigen[
49] (from PEN1, 2, and 3 strains), as described[
49,
50], was used for IgG and IgA determination. In brief,
C. jejuni cells were harvested in sterile water, washed twice with water and 0.1 g of wet cells were suspended in 2.5 ml 0.2 M glycine-hydrochloride buffer (pH 2.2). Suspensions were stirred at 25°C for 15 min and centrifuged at 11,000 x g for 15 min. The supernatant was collected and sodium hydroxide was added to neutralize the suspension. Next, the suspension was dialyzed against water for 24 h at 4°C and the protein concentration was determined. ELISA was performed as described for
H. pylori. Monkey sera were diluted 1:200 and goat anti-monkey IgG (gamma chain) or IgA (alpha chain) conjugated to horseradish peroxidase (Rockland Immunochemicals Inc., Gilbertsville, PA) (1:2000) was used as the secondary antibody. OD
405 values were normalized using a known positive human control serum (1:200) to compare ODR. Each sample was tested 2–3 times, as described above.
Determination of cut-off values for C. jejuni IgG ELISAs
To initially determine a range to examine seropositivity, the mean of sera with ODRs between 0.000-0.299 was calculated and 2 intervals of SD were added, obtaining an initial negative cut-off of 0.338. Next, the mean of ODRs between 0.4-1.0 was calculated and 2 SD intervals substracted resulting in a positive cut-off of 0.318. We also used 10 serum samples from C. jejuni-positive persons and 16 serum samples from C. jejuni-negative persons. The calculated negative cut-off was 0.362 and the positive was 0.418. We calculated the mean value for these three tentative cut-offs, and established a cut-off of 0.340 as an alternative means to define the thresholds for positivity and negativity.
Determination of cut-off values for C. jejuni IgA ELISAs
IgA cut-offs were calculated as described for IgG. Since the negative cut-off was 0.368 and the positive cut-off was 0.326, we used a cut-off of 0.350 to analyze Cohort 2.
Acknowledgements
This paper is dedicated to the memory of our colleague, Andre Dubois, M.D., Ph.D., who was deeply involved with the creation of this study and its conduct, but who did not survive until its publication. We remember Andre as a true scientist and a great friend.
This study was supported by RO 1GM6370 (MJB), RR003640 (Caribbean Primate Research Center, University of Puerto Rico-Medical Sciences Campus) and the MBRS-RISE Program of the University of Puerto Rico at Rio Piedras (JLRC), 5P20RR016470 (RTA) and 8P20GM103475 (RTA) from the National Institutes of Health, the Bill and Melinda Gates Foundation and the Diane Belfer Program in Human Microbial Ecology (MJB), the Michael Saperstein Medical Scholars Program (SK).
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SK participated in the study design, carried out experiments, analyzed the data and drafted the manuscript. GPP carried out experiments and analyzed the data from cohort 1. JLRC and RTA performed immunoassays and helped to analyze the data. HL participated in the statistical analysis of the data. AD created and designed the study and analyzed the biopsies, JAGM provided plasma samples. MGDB and MJB participated in the design of the study and helped to analyze the data and to draft the manuscript. All authors read and approved the final manuscript.